EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach

M B I Lobbes, M E Kooi, E Lutgens, A W Ruiters, V Lima Passos, S H J G Braat, M Rousch, H Ten Cate, J M A van Engelshoven, M J A P Daemen, S Heeneman

International Journal of Vascular Medicine · 2010

DOI: 10.1155/2010/726207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Vascular Medicine, 2010. Verfasst von M B I Lobbes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Cardiovascular Research Institute Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Dutch Heart Foundation, European Community’s Sixth Framework Program for Research, Besluit Subsidies Investeringen Kennisinfrastructuur.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We evaluated leukocyte counts and levels of CRP, fibrinogen, MPO, and PAPP-A in patients with stable and unstable angina pectoris, acute myocardial infarction, and healthy controls. All biomarkers were analyzed again after 6 months. Leukocyte counts and concentrations of fibrinogen, CRP, MPO, and PAPP-A were significantly increased in patients with acute myocardial infarction. Leukocyte counts and concentrations of MPO were significantly increased in patients with unstable angina pectoris compared with controls. After 6 months, leukocyte counts and MPO concentrations were still increased in patients with acute myocardial infarction when compared to controls. Discriminant analysis showed that leukocyte counts, MPO, and PAPP-A concentrations classified study group designation for acute coronary events correctly in 83% of the cases. In conclusion, combined assessment of leukocyte counts, MPO, and PAPP-A was able to correctly classify acute coronary events, suggesting that this could be a promising panel for a multibiomarker approach to assess cardiovascular risk.

Autor:innen und Institutionen

  • Department of Pathology, Cardiovascular Research Institute Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.

Förderung

  • Dutch Heart Foundation
  • European Community’s Sixth Framework Program for Research
  • Besluit Subsidies Investeringen Kennisinfrastructuur

Zitieren

APA

Lobbes, M. B., Kooi, M. E., Lutgens, E., Ruiters, A. W., Lima Passos, V., Braat, S. H., Rousch, M., Ten Cate, H., van Engelshoven, J. M., Daemen, M. J., & Heeneman, S. (2010). Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach. International Journal of Vascular Medicine. https://doi.org/10.1155/2010/726207

Vancouver

Lobbes MB, Kooi ME, Lutgens E, Ruiters AW, Lima Passos V, Braat SH, et al. Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach. International Journal of Vascular Medicine. 2010. doi:10.1155/2010/726207

BibTeX
@article{Lobbes2010,
  author = {Lobbes, M B I and Kooi, M E and Lutgens, E and Ruiters, A W and Lima Passos, V and Braat, S H J G and Rousch, M and Ten Cate, H and van Engelshoven, J M A and Daemen, M J A P and Heeneman, S},
  title = {Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach},
  journal = {International Journal of Vascular Medicine},
  year = {2010},
  doi = {10.1155/2010/726207}
}
Kostenlos starten →